WallStreetZenWallStreetZen

NASDAQ: SSKN
Strata Skin Sciences Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their SSKN stock forecasts and price targets.

Forecast return on equity

Is SSKN forecast to generate an efficient return?

Company
-473.07%
Industry
20.7%
Market
342.54%
SSKN's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is SSKN forecast to generate an efficient return on assets?

Company
-20.24%
Industry
11.67%
SSKN is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

SSKN earnings per share forecast

What is SSKN's earnings per share in the next 2 years based on estimates from 4 analysts?

Avg 1 year Forecast
-$1.41
Avg 2 year Forecast
-$1.06

SSKN revenue forecast

What is SSKN's revenue in the next 2 years based on estimates from 4 analysts?

Avg 1 year Forecast
$32.9M+6.05%
Avg 2 year Forecast
$35.9M+15.96%
SSKN's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

SSKN revenue growth forecast

How is SSKN forecast to perform vs Medical Devices companies and vs the US market?

Company
6.05%
Industry
12.57%
Market
1,473.76%
SSKN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
SSKN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

SSKN vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
SSKN$1.34N/AN/A
PTHL$0.47N/AN/A
XAIR$0.95$11.00+1,053.04%Strong Buy
BMRA$2.88N/AN/A
PAVM$7.29$510.00+6,895.88%Buy
View Top Medical Device Stocks

Strata Skin Sciences Stock Forecast FAQ

What is SSKN's earnings growth forecast for 2026-2027?

(NASDAQ: SSKN) Strata Skin Sciences's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 39.74%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 3,144.19%.

Strata Skin Sciences's earnings in 2026 is -$11,040,000.On average, 4 Wall Street analysts forecast SSKN's earnings for 2026 to be -$8,324,147, with the lowest SSKN earnings forecast at -$8,540,244, and the highest SSKN earnings forecast at -$7,987,931.

In 2027, SSKN is forecast to generate -$6,216,172 in earnings, with the lowest earnings forecast at -$6,405,183 and the highest earnings forecast at -$5,935,305.

If you're new to stock investing, here's how to buy Strata Skin Sciences stock.

What is SSKN's revenue growth forecast for 2026-2027?

(NASDAQ: SSKN) Strata Skin Sciences's forecast annual revenue growth rate of 6.05% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 12.57%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 1,473.76%.

Strata Skin Sciences's revenue in 2026 is $30,980,000.On average, 4 Wall Street analysts forecast SSKN's revenue for 2026 to be $193,450,890, with the lowest SSKN revenue forecast at $182,593,051, and the highest SSKN revenue forecast at $202,648,257.

In 2027, SSKN is forecast to generate $211,521,773 in revenue, with the lowest revenue forecast at $200,852,356 and the highest revenue forecast at $220,295,189.

What is SSKN's forecast return on assets (ROA) for 2026-2027?

(NASDAQ: SSKN) forecast ROA is -20.24%, which is lower than the forecast US Medical Devices industry average of 11.67%.

What is SSKN's Earnings Per Share (EPS) forecast for 2026-2027?

(NASDAQ: SSKN) Strata Skin Sciences's current Earnings Per Share (EPS) is -$2.67. On average, analysts forecast that SSKN's EPS will be -$1.41 for 2026, with the lowest EPS forecast at -$1.45, and the highest EPS forecast at -$1.36. In 2027, SSKN's EPS is forecast to hit -$1.06 (min: -$1.09, max: -$1.01).

What is SSKN's forecast return on equity (ROE) for 2026-2027?

(NASDAQ: SSKN) forecast ROE is -473.07%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.